Who is Mikhail Blagosklonny?

An oncologist is a medical practitioner who treats cancer and tumors. One of the more famous oncologists is Mikhail Blagosklonny who is a professor of oncology at the Roswell Park Cancer Institute in New York. Mikhail is currently studying and teaching cancer and aging. He went to the First Pavlov State Medical University of St. Petersburg where he earned an MD in Internal Medicine. There, he also earned a Ph.D. in Experimental Medicine and Cardiology. In 2002, Mikhail was made an associate professor at the New York Medical College. View his LinkedIn profile

Then he went on to Ordway Research Institute and worked as the senior scientist. In 2009, Mikhail became the professor of oncology at Roswell Park Cancer Institute and his research involves mechanisms of aging, anti-aging, and cancer therapies. He credits the different places and experiences he work at in helping him become the excellent professor he is today. Mikhail is also an author and wrote many articles and publications. He wrote theories about controlling aging and he believes cancer will be cured someday. Mikhail works an associate editor of cancer biology and therapy. Mikhail wrote a hypothesis about TOR Signaling potential role in cancer and aging. He recommended using a drug called Rapamycin which is used in treating cancer. Mikhail believes this may be a possible treatment in the longevity research. Mikhail Blagosklonny’s dedication, hard work and passion for his work have contributed to his achievement of becoming one of the biggest names in oncology research. He says that his love for humanity and the vision of curing diseases is what drives him everyday.

Learn more http://gettingstronger.org/tag/mikhail-blagosklonny/

Contributions of Mikhail Blagosklonny to Cancer Research and Anti-aging

Mikhail Blagosklonny holds a position as the chief editor of Cell Cycle and Oncotarget. He is an associate of other publications that focus on the treatment of cancer. He is known for his skills in therapy and biology of cancer on Wikipedia.org. Mikhail is also on the editorial board of Cell Death and Differentiation. He is popular for his hypothesis in TOR which seeks to explore the relationship between cancer and aging. He has reportedly used Rapamycin to a carry out his research. Rapamycin is a popular drug used to treat cancer. Mikhail has shown a considerable zeal and approach to finding the latest approach to cancer therapy.

The longevity of cancer treatment research has seen him become labeled as one of the most passionate advocates of the Rapamycin research. Mikhail Blagosklonny research varies from molecular biology, cellular biology to several clinical investigations. He has researched in other sections such as drug resistance of healthy cells, tumor suppressors, cell cycle, and anticancer therapeutics.

Blagosklonny has a thorough understanding of the field of medicine. He earned his Medical Doctorate in the field of internal medicine. He later received a Ph.D. in the area of cardiology and medicine. He was able to attend the Russian Medical University and the First Pavlov Medical University. Blagosklonny’s experience in cancer research at https://www.researchgate.net/profile/Mikhail_Blagosklonny saw him become appointed as an associate professor of medicine at the New York Medical School. He held this position for some time in the year 2002 before earning a position as Senior Scientist at the Ordway Research Institute in Albany, New York. Blagosklonny was able to hold this position until 2009 before he became appointed as Professor of Oncology at the Roswell Park Institute of Cancer.

Mikhail Blagosklonny has focused his research in the field of cancer and its therapies that protect cells from getting damaged. He is famous for his studies in the area of aging and coming up with anti-aging drugs. During his research, he was able to hypothesize the working of the Rapamycin enzyme. The enzyme is popularly acclaimed for its positive effects in cancer treatment. He was able to see how the drug prolonged the lives of cells and therefore prevented aging.